#160 #160#160 #160#160 #160#160 #160The “peanut butter and jelly sandwich patent” has been a hot topic lately, from television news broadcasters to intellectual property commentators.#160 The triggering event was a Wall Street Journal article on April 5, 2005 concerning a hearing to be held that day by the Federal Circuit Court of
Patent Law
The Federal Circuit Invalidates SmithKline Beecham’s Paxil�� Patent For Inherent Anticipation – Based On SmithKline’s Own Arguments
By Weintraub Firm on
Posted in Patent Law
By Pamela Winston Bertani
Last month in a patent infringement suit involving SmithKline Beecham’s patent for the active ingredient in its antidpressent drug Paxil��, the Federal Circuit affirmed judgment in defendant’s favor where SmithKline Beecham’s patent was held invalid as anticipated under 35 U.S.C. Section 102 – for being inherently disclosed in a …
The United States Supreme Court Will Examine The 35 U.S.C. �� 271 FDA Exemption From Patent Infringement – Biotechnology Companies Beware
By Weintraub Firm on
Posted in Patent Law
By Pamela W. Bertani
#160 #160#160 #160#160 #160 Biotechnology and pharmaceutical companies – and their counsel – should take note that on January 7, 2005, the United States Supreme Court granted a writ of certiorari to review the Federal Circuit’s decision in Integra v. Merck.#160 (Integra Lifescienxes v. Merck et al. …
The Federal Circuit Strictly Enforces Bayh-Dole Act Disclosure Requirements: Noncompliance Could Result In Forfeiting Patent Rights
By Weintraub Firm on
Posted in Patent Law
By#160 Pamela Winston Bertani
Pamela W. Bertani is an associate in Weintraub Genshlea Chediak Tobin & Tobin Sproul’s Intellectual Property group.#160 Her practice includes providing advice in obtaining various forms of intellectual property protection, including patent, trademark, and copyright protection.#160 Ms. Bertani is a member of the United States Patent Bar, and her …